Tonghua Dongbao Pharmaceutical Co., Ltd. provided earnings guidance for the first half of 2015. The company predicts a year-on-year increase of about between 70% and 80% in the net profit belonging to shareholders of the parent company in the first Half of 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.48 CNY | +1.31% | -1.74% | -21.70% |
21/06 | Dongbao Pharmaceutical Doses First Patient in Diabetes Drug Trial | MT |
15/05 | Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.70% | 2.27B | |
+1.92% | 95.18B | |
-0.13% | 37.55B | |
-10.43% | 33.75B | |
+77.76% | 28.2B | |
-14.82% | 15.63B | |
-3.06% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |
- Stock Market
- Equities
- 600867 Stock
- News Tonghua Dongbao Pharmaceutical Co., Ltd.
- Tonghua Dongbao Pharmaceutical Co., Ltd. Provides Earnings Guidance for the First Half of 2015